ITGA5 and gastric cancer: In summary, the current study detailed the anti-carcinogenic action of the miR-148/152 family members in gastric cancer development through its interplay with ITGA5, thus offering a novel therapeutic target for developing effective treatment modalities against gastric cancer (Fig. 7).